Health Trials

Relapsed/Refractory Multiple Myeloma (MM)

2

Review clinical trials related to Relapsed/Refractory Multiple Myeloma (MM). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma.

Participants needed: 3
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Chulalongkorn UniversityUpdated: Mar 9, 2026Locations: 1
Eligibility criteria

Age above 18 years old (inclusive), regardless of gender. [+19]

Subjects with a known history of allergy, hypersensitivity, intolerance, or cont... [+27]

Read more
Status: Recruiting

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

A Phase 1a/1b Open-Label Study with Dose Escalation and Expansion Phases to Evaluate Safety and Preliminary Efficacy of Naïve HBI0101 CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma.

Participants needed: 60
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Hadassah Medical OrganizationUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

≥18 years of age at the time of signing informed consent. [+17]

Contraindication to a study treatment/procedure or is anticipated to receive tre... [+18]

Read more